Insight

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Collage photo of Marco Ruella and Ruchi Patel

Jul 21, 2024, 21:50

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at the University of Pennsylvania, shared a post on X about a recent paper by Ruchi Patel et al. published in Science Immunology, commenting:

“Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models.”

“CD5 deletion enhances the antitumor activity of adoptive T cell therapies”

Authors: Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, Patrizia Porazzi, Marco Ruella et al.

Source: Marco Ruella/X

Aasha Gupta cancer CART immunotherapy Guido Ghilardi liquid cancer models Marco Ruella Nicholas Siciliano Olga Shestova OncoDaily Oncology Ositadimma Ugwuanyi Patrizia Porazzi Puneeth Guruprasad Raymone Pajarillo Ruchi Patel Science Immunology solid cancer models University of Pennsylvania Yi-Hao Chiang Yong Gu Lee Yunlin Zhang

Why President Biden Values Cancer Research So Much: The Story Behind Cancer Moonshot

The 2024 NIH Director’s Awards

Tedros Adhanom Ghebreyesus Received 2024 Rebranding Africa Forum Governance Leadership Award

Highlights from SIOP 2024 Congress

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 8

Special Coverage